[HTML] cell.comFull View

[HTML][HTML] Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - Cell metabolism, 2018 - cell.com
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …
被引用次数：224 相关文章

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - Cell …, 2018 - pubmed.ncbi.nlm.nih.gov
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …
[PDF] core.ac.uk

[PDF][PDF] Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari, FP Daniel… - core.ac.uk
Microenvironment is known to influence cancer drug response and sustain resistance to
therapies targeting receptor-tyrosine kinases. However if and how tumor microenvironment …
[HTML] cell.com

[HTML][HTML] Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - Cell Metabolism, 2018 - cell.com
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - CELL …, 2018 - arpi.unipi.it
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - Cell …, 2018 - europepmc.org
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …
[HTML] sciencedirect.com

[HTML][HTML] Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - Cell Metabolism, 2018 - Elsevier
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannone, S Fiore, K Ferrari… - CELL …, 2018 - iris.unito.it
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - CELL …, 2018 - flore.unifi.it
The microenvironment influences cancer drug response and sustains resistance to
therapies targeting receptor-tyrosine kinases. However, if and how the tumor …

[引用][C] Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

M Apicella, E Giannoni, S Fiore, KJ Ferrari… - Cell Metabolism, 2018 - cir.nii.ac.jp
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive
Resistance to MET and EGFR Targeted Therapies | CiNii Research CiNii 国立情報学研究所 学術 …